MedDataX Logo

Therapeutic Massage for Generalized Anxiety Disorder

NCT ID: NCT00515242

Last Updated: 2017-10-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1/PHASE2

Total Enrollment

68 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-09-30

Study Completion Date

2009-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare the relative effectiveness of three relaxation treatments (therapeutic massage, thermotherapy, and time in a relaxing environment) in reducing anxiety in persons with Generalized Anxiety Disorder.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Anxiety and stress are costly problems that afflict millions of American adults. Together, they are among the most common reasons for which adults use complementary and alternative medical (CAM) therapies as well as more conventional relaxation therapies. Although massage is one of the most popular CAM treatments for anxiety, its effectiveness for this problem has never been rigorously evaluated. This study is designed to evaluate the effectiveness of massage as a treatment for a diagnosed anxiety disorder. Massage will be compared with two other relaxing treatments: thermotherapy and time in a relaxing environment, which reflect the types of activities that persons with anxiety might try to relieve their symptoms.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Generalized Anxiety Disorder

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

massage therapy relaxation treatments

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Therapeutic massage

Group Type EXPERIMENTAL

massage

Intervention Type BEHAVIORAL

therapeutic massage

2

Thermotherapy

Group Type ACTIVE_COMPARATOR

thermotherapy

Intervention Type BEHAVIORAL

heat therapy

3

Relaxation

Group Type PLACEBO_COMPARATOR

relaxing environment

Intervention Type BEHAVIORAL

time in a relaxing environment

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

massage

therapeutic massage

Intervention Type BEHAVIORAL

thermotherapy

heat therapy

Intervention Type BEHAVIORAL

relaxing environment

time in a relaxing environment

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Member of Group Health, Seattle metropolitan area
* Generalized Anxiety Disorder confirmed by SCID
* At least moderate anxiety

Exclusion Criteria

* Serious mental health co-morbidity
* Any life threatening condition
* Currently receiving psychotherapy
* Substantial alcohol use
* Contraindications for massage
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Center for Complementary and Integrative Health (NCCIH)

NIH

Sponsor Role collaborator

Kaiser Permanente

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Karen J. Sherman, PhD, MPH

Role: PRINCIPAL_INVESTIGATOR

Group Health

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Group Health Research Institute

Seattle, Washington, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R21AT002560

Identifier Type: NIH

Identifier Source: secondary_id

View Link

R21AT002560

Identifier Type: NIH

Identifier Source: org_study_id

View Link